Discover the powerful role that patient and caregiver advocacy plays in shaping health systems and enhancing ovarian cancer care. In this session, we’ll explore how Ovarian Cancer Canada (OCC) identifies gaps in care through patient experiences and how these insights impact advocacy efforts. Learn how OCC equips individuals to advocate for themselves and their communities, using real-world examples like the successful patient-led submission for mirvetuximab soravtansine (ELAHERE) and the expansion of gynecologic cancer services in British Columbia. We’ll also highlight OCC's collaborations with coalitions and organizations, emphasizing the strength of unified efforts in driving systemic change. Looking ahead, we will focus on upcoming projects and define the health system changes OCC aims to influence.
This session was part of Ovarian Cancer Canada's 2025 National Symposium.
Speaker bio:
Alexandria Tadman is the Government Relations and Advocacy Lead at Ovarian Cancer Canada, where she has been driving advocacy efforts since 2022. With a strong foundation in the not-for-profit sector both in Canada and internationally and a joint Master’s degree, Alexandria brings a wealth of experience in health policy and system change. Prior to joining OCC, she spent five years with the Ontario Provincial Government, including as a Senior Policy Advisor at the Ministry of Health. Passionate about improving healthcare through collaboration, she works closely with patient advocates to advance meaningful change.